Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

25.06 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Pfizer

< Previous 1 2
...
32 33 34 35 36 37 38 39 Next >
News headline image
Pfizer and BioNTech Announce Positive Topline Results From Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years
From Pfizer Inc.
Via Business Wire
News headline image
FDA Advisory Committee Votes Unanimously in Favor Of COMIRNATY® Booster for Emergency Use in People 65 and Older and Certain High-risk Populations
From Pfizer Inc.
Via Business Wire
News headline image
Major Study Finds COVID Vaccines Highly Effective in Preventing Hospitalizations, ICU Admissions, and Emergency Visits
This press release was orginally distributed by ReleaseWire 
Via ReleaseWire
News headline image
Multivitamins Market to Witness Massive Growth by 2027: GNC, AMWAY, Eisai ↗
Stay up-to-date with Multivitamins Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Topics Intellectual Property
News headline image
COVID-19 and Fertility Clinic Sperm Count
Trying to conceive? Fertility clinic in Vancouver shares data indicating sperm counts unaffected by vaccine. 
Via ReleaseWire
News headline image
Dietary Supplements Market Growth Opportunities and Recent Developments ↗
Northbrook, IL -- (SBWIRE) -- 09/09/2021 -- Dietary Supplements Market by Type (Vitamins, Minerals, Botanicals, Amino acids, Enzymes, Probiotics), Function (Additional, Medicinal, Sports Nutrition),... 
Via SBWire
News headline image
UK’s MHRA Grants Marketing Authorisation for Pfizer’s CIBINQO® (abrocitinib) for Adults and Adolescents With Moderate to Severe Atopic Dermatitis
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Invites Public to Listen to Two Webcasts of Pfizer Discussions at Upcoming Healthcare Conferences
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Announces Start of Phase 3 Clinical Trial in Adults for Its Investigational Vaccine Against Respiratory Syncytial Virus (RSV)
From Pfizer Inc.
Via Business Wire
News headline image
Solar UV Treatment of Covid-19 by Nanoparticles?
A single dose of Moderna is shown to contain a number of nanoparticles that provide UV intensity comparable to solar UVB on the Earth's surface. 
Via iCrowdNewswire
News headline image
Will European Research Into the Mixing of AstraZeneca & Pfizer Vaccines Help to Push the Global Vaccine Rollout
Berlin, Germany -- (SBWIRE) -- 08/31/2021 -- As the international battle with coronavirus continues, scientists in Europe have been testing the efficacy of mixing the AstraZeneca vaccine with the... 
Via SBWire
ORIGINS Pharmacy Offers COVID-19 Vaccinations in Milton
Via Get News
News headline image
Positive Top-Line Results From Pfizer’s Phase 3 JADE DARE Trial Comparing the Efficacy of Abrocitinib and Dupilumab for Moderate to Severe Atopic Dermatitis
From Pfizer Inc.
Via Business Wire
NextGen Healthcare: TempDev’s COVID-19 Vaccine NextGen EHR Template Upgraded to Work with Pfizer and Moderna Boosters
Via AB Newswire
News headline image
Pfizer Announces New Chief Business Innovation Officer
From Pfizer Inc.
Via Business Wire
News headline image
Cold Pain Therapy Market Worth $2.0 Billion – Increasing Regulatory Barriers for Oral Pain Medications ↗
The global cold pain therapy market size is projected to reach USD 2.0 billion by 2025 from USD 1.6 billion in 2020, at a CAGR of 4.4% during the forecast period 
Via SBWire
News headline image
Pfizer and BioNTech Announce Collaboration With Brazil’s Eurofarma to Manufacture COVID-19 Vaccine Doses for Latin America
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer and BioNTech Initiate Rolling Submission of Supplemental Biologics License Application to U.S. FDA for Booster Dose of COMIRNATY® in Individuals 16 and Older
From Pfizer Inc.
Via Business Wire
Virus Filtration Market To Lift Up Industry Growth During The Forecast Period From 2019 – 2026 | Grand View Research, Inc.
Via AB Newswire
News headline image
Children Cough Medicine Market to See Huge Growth by 2021-2026 : Bayer, Sanofi, Hyland's ↗
The latest analysis released by HTF MI on "Worldwide Children Cough Medicine Market Outlook 2020 Survey results" sheds light on how investment and competitive landscape is impacted due to significant... 
Via SBWire
Topics Supply Chain
News headline image
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer to Acquire Trillium Therapeutics Inc.
From Pfizer Inc.
Via Business Wire
News headline image
XELJANZ® (tofacitinib citrate) Receives Marketing Authorization in the European Union for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis
From Pfizer Inc.
Via Business Wire
Insight on Ophthalmic Drugs Global Market to 2028 | Featuring Bayer, Abbott ,Pfizer, Novartis
Via AB Newswire
Active Pharmaceutical Ingredients Market worth $248.3 billion by 2025 | Key Players are Pfizer Inc. (US), Novartis International AG (Switzerland), Merck & Co. (US)
Via AB Newswire
CannabisNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Names Former J&J Director as New Chief Scientific Officer
Via CannabisNewsWire
News headline image
Advancement in Connectivity Technology Expected to Enhance the Growth of the Biosimilars Market During the Projected Period 2021-2027
Advancement in Connectivity Technology Expected to Enhance the Growth of the Biosimilars Market during the Projected Period 2021-2027 
Via SBWire
Topics Economy
News headline image
Pfizer Prices $1.0 Billion Sustainability Bond
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer and BioNTech Announce Submission of Initial Data to U.S. FDA to Support Booster Dose of COVID-19 Vaccine
From Pfizer Inc.
Via Business Wire
News headline image
U.S. FDA Approves TICOVAC™, Pfizer’s Tick-Borne Encephalitis (TBE) Vaccine
From Pfizer Inc.
Via Business Wire
< Previous 1 2
...
32 33 34 35 36 37 38 39 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.